BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 15793720)

  • 21. Low-density lipoproteins oxidized after intestinal ischemia/reperfusion in rats.
    Tekin IO; Sipahi EY; Comert M; Acikgoz S; Yurdakan G
    J Surg Res; 2009 Nov; 157(1):e47-54. PubMed ID: 19482302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model.
    Aprahamian CJ; Lorenz RG; Harmon CM; Dimmit RA
    Pediatr Crit Care Med; 2008 Jan; 9(1):105-9. PubMed ID: 17906593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of protein kinase C in intestinal ischemic preconditioning.
    Um JW; Matthews JB; Song JC; Mun EC
    J Surg Res; 2005 Apr; 124(2):289-96. PubMed ID: 15820260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut.
    Chen Y; Lui VC; Rooijen NV; Tam PK
    Gut; 2004 Dec; 53(12):1772-80. PubMed ID: 15542513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-10 is not protective in intestinal ischemia reperfusion injury.
    Stallion A; Kou TD; Miller KA; Dahms BB; Dudgeon DL; Levine AD
    J Surg Res; 2002 Jun; 105(2):145-52. PubMed ID: 12121701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome.
    Pastores SM; Katz DP; Kvetan V
    Am J Gastroenterol; 1996 Sep; 91(9):1697-710. PubMed ID: 8792684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Investigation of postconditioning in intestinal ischemia-reperfusion experimental models].
    Rosero O; Onody P; Stangl R; Hegedus V; Lotz G; Blázovics A; Kupcsulik P; Szijártó A
    Magy Seb; 2011 Feb; 64(1):28-36. PubMed ID: 21330261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intestinal ischemic reperfusion syndrome: pathophysiology, clinical significance, therapy].
    Schwarz B; Salak N; Hofstötter H; Pajik W; Knotzer H; Mayr A; Hasibeder W
    Wien Klin Wochenschr; 1999 Jul; 111(14):539-48. PubMed ID: 10467640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring platelet aggregation to estimate small intestinal ischemia-reperfusion injury.
    Arakawa K; Takeyoshi I; Muraoka M; Matsumoto K; Morishita Y
    J Surg Res; 2004 Dec; 122(2):195-200. PubMed ID: 15555618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenteric ischemia/reperfusion-induced intestinal and vascular damage: effect of stobadine.
    Nosál'ová V; Navarová J; Mihalová D; Sotníková R
    Methods Find Exp Clin Pharmacol; 2007; 29(1):39-45. PubMed ID: 17344943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pancreatic Enzymes and intestinal Ischemia].
    Löhr JM; Benz S
    Z Gastroenterol; 2002 Feb; 40(2):147-8. PubMed ID: 11857105
    [No Abstract]   [Full Text] [Related]  

  • 33. Tyrosine: a possible marker of severe intestinal injury during ischemia.
    Contrin LM; Lobo SM; Navegantes LC; Orrico SP; Queiroz MM; Cury PM; Lira EC; Carta A; Yamamoto AE; Vincent JL
    J Surg Res; 2009 Aug; 155(2):268-72. PubMed ID: 19505700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxemic reperfusion after 120 mins of intestinal ischemia attenuates the histopathologic and inflammatory response.
    Douzinas EE; Kollias S; Tiniakos D; Evangelou E; Papalois A; Rapidis AD; Tsoukalas GD; Patsouris E; Roussos C
    Crit Care Med; 2004 Nov; 32(11):2279-83. PubMed ID: 15640642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal ischemia/reperfusion injury aggravates talc-induced adhesions in rats.
    Murata P; Kase Y; Tokita Y; Takeda S; Sasaki H
    J Surg Res; 2006 Sep; 135(1):45-51. PubMed ID: 16650869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury.
    Pompermayer K; Amaral FA; Fagundes CT; Vieira AT; Cunha FQ; Teixeira MM; Souza DG
    Eur J Pharmacol; 2007 Feb; 556(1-3):215-22. PubMed ID: 17182029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose inhaled carbon monoxide attenuates the remote intestinal inflammatory response elicited by hindlimb ischemia-reperfusion.
    Scott JR; Cukiernik MA; Ott MC; Bihari A; Badhwar A; Gray DK; Harris KA; Parry NG; Potter RF
    Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G9-G14. PubMed ID: 19114681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of sildenafil on the functional and structural changes of ileum induced by intestinal ischemia-reperfusion in rats.
    Soydan G; Sökmensüer C; Kilinç K; Tuncer M
    Eur J Pharmacol; 2009 May; 610(1-3):87-92. PubMed ID: 19303867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesna protects intestinal mucosa from ischemia/reperfusion injury.
    Ypsilantis P; Lambropoulou M; Tentes I; Kortsaris A; Papadopoulos N; Simopoulos C
    J Surg Res; 2006 Aug; 134(2):278-84. PubMed ID: 16500680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut dysfunction in critically ill patients: a review of the literature.
    Stechmiller JK; Treloar D; Allen N
    Am J Crit Care; 1997 May; 6(3):204-9. PubMed ID: 9131199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.